PreciHealth

Neuchâtel, Switzerland

Device DevelopmentDiagnostic DevicesHome-Based CareConnected Health

PreciHealth is a Swiss company that has developed the world’s first and only at home self-authenticating auto-injectors and blood collectors. The company was founded in 2017 as a medical spinoff of Preciflex, a leading enterprise that offers creative engineering solutions in the fields of micromechanics and microfluidics. Unlike existing solutions, the PreciHealth platform enables governments and HMOs to perform en masse at-home vaccinations, injections and blood screenings, in which the patient's identity is authenticated, so there is no risk of patient mix-up or fraud. Furthermore, following each procedure, the patient receives a certification, and the procedure details can be seamlessly integrated into the HMO’s database. The relevance of PreciHealth’s solution has never been more acute. With the growing Covid-19 pandemic and the need to vaccinate millions of people, PreciHealth offers an efficient and cost-effective solution that can play a major role in curbing the pandemic.The PreciHealth platform is simple and easy to use. Once a patient receives the PreciHealth kit, s/he downloads a designated application that guides him/her throughout the procedure and verifies its completion. The procedure itself is fast and painless. PreciHealth has developed patented micro-sized needles and lancets capable of penetrating the skin with unprecedented precision using very low force. The auto-injectors use an invisible needle which significantly reduces needle phobia. Furthermore, the needle penetrates the skin at an oblique angle which eliminates any needle injuries. The blood collection device uses a micro-lancet that creates a minute incision in the skin. The procedure takes only 10 minutes, yet delivers a high volume of capillary blood of between 150 μl to 2 ml of blood.The PreciHealth management team consists of seasoned executives experienced in developing and marketing innovative medical devices.